BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21171084)

  • 1. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
    J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
    Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
    J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
    Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Dong G; Zhang W; Ibrahim AE; Arends MJ
    Int J Exp Pathol; 2014 Feb; 95(1):8-15. PubMed ID: 24354449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis of urethane-induced lung tumors in ras H2 mice.
    Okamura M; Unami A; Matsumoto M; Oishi Y; Kashida Y; Mitsumori K
    Toxicology; 2006 Jan; 217(2-3):129-38. PubMed ID: 16289808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Necl-5 in the pathophysiology of colorectal lesions induced by dimethylhydrazine and/or dextran sodium sulphate.
    Abe A; Fukui H; Fujii S; Kono T; Mukawa K; Yoshitake N; Sekikawa A; Ichikawa K; Tomita S; Yamagishi H; Imai Y; Shinoda M; Ishizaki H; Tanaka-Okamoto M; Kubota K; Miyoshi J; Takai Y; Fujimori T
    J Pathol; 2009 Jan; 217(1):42-53. PubMed ID: 18973187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas.
    James RM; Arends MJ; Plowman SJ; Brooks DG; Miles CG; West JD; Patek CE
    Mol Cancer Res; 2003 Sep; 1(11):820-5. PubMed ID: 14517344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
    Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway.
    Patel R; Ingle A; Maru GB
    Toxicol Appl Pharmacol; 2008 Feb; 227(1):136-46. PubMed ID: 18037152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
    Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
    Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal instability and APC gene mutations in human sporadic colorectal adenomas.
    Giaretti W; Venesio T; Prevosto C; Lombardo F; Ceccarelli J; Molinu S; Risio M
    J Pathol; 2004 Oct; 204(2):193-9. PubMed ID: 15376262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
    Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
    Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
    Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
    Céspedes MV; Sancho FJ; Guerrero S; Parreño M; Casanova I; Pavón MA; Marcuello E; Trias M; Cascante M; Capellà G; Mangues R
    Carcinogenesis; 2006 Nov; 27(11):2190-200. PubMed ID: 16679305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.
    Paoni NF; Feldman MW; Gutierrez LS; Ploplis VA; Castellino FJ
    Physiol Genomics; 2003 Nov; 15(3):228-35. PubMed ID: 13130079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.